Hospital or health organisation · founded 1908
Beaumont Hospital, Troy
Troy, United States · beaumont.org/locations/beaumont-hospital-troy
Part of Corewell Health
- Citations, last 5 years
- 586
- Works, last 5 years
- 249
- h-index
- 145
- Scientists listed
- 0
- Grants since 2016
- 47
Grants received
2025–2029 · research · R01
Develop a novel multi-approach dynamic Spot Scanning Proton Arc optimization framework
Xuanfeng Ding · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
The role of amphiregulin in mediating radiation cystitis in cancer survivors
Bernadette Margaretha Maria Zwaans · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
The role of amphiregulin in mediating radiation cystitis in cancer survivors
Bernadette Margaretha Maria Zwaans · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
Quinolinate-induced immune suppression in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
Sacral neuromodulation for the management of chronic pelvic pain
Priya Padmanabhan · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
Quinolinate-induced immune suppression in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
Sacral neuromodulation for the management of chronic pelvic pain
Priya Padmanabhan · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
Quinolinate-induced immune suppression in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
Sacral neuromodulation for the management of chronic pelvic pain
Priya Padmanabhan · Beaumont Hospital, Troy · funded by National Institutes of Health
2023–2028 · research · R01
The role of amphiregulin in mediating radiation cystitis in cancer survivors
Bernadette Margaretha Maria Zwaans · Beaumont Hospital, Troy · funded by National Institutes of Health
2021–2025 · research · R01
Incorporation of multilevel ontologies of adverse events and vaccines for vaccine safety surveillance
Lili Zhao · Beaumont Hospital, Troy · funded by National Institutes of Health
2021–2025 · research · R01
Incorporation of multilevel ontologies of adverse events and vaccines for vaccine safety surveillance
Lili Zhao · Beaumont Hospital, Troy · funded by National Institutes of Health
2021–2025 · research · R01
Incorporation of multilevel ontologies of adverse events and vaccines for vaccine safety surveillance
Lili Zhao · Beaumont Hospital, Troy · funded by National Institutes of Health
2021–2023 · program · P20
Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE)
Michael B Chancellor · Beaumont Hospital, Troy · funded by National Institutes of Health
2021–2024 · program · P20
Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE)
Bernadette Margaretha Maria Zwaans · Beaumont Hospital, Troy · funded by National Institutes of Health
2021–2024 · program · P20
MI-CURE Admin
Michael B Chancellor · Beaumont Hospital, Troy · funded by National Institutes of Health
2021–2024 · program · P20
MI-CURE Research Project
Sara Roccabianca · Beaumont Hospital, Troy · funded by National Institutes of Health
2020–2026 · research · R01
Multicenter Quantitative MRI Assessment of Breast Cancer Therapy Response
James H Holmes · Beaumont Hospital, Troy · funded by National Institutes of Health
2020–2023 · research · R21
Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline?
Emma Louise Cunningham · Beaumont Hospital, Troy · funded by National Institutes of Health
2020–2026 · research · R33
Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline?
Emma Louise Cunningham · Beaumont Hospital, Troy · funded by National Institutes of Health
2020–2026 · research · R33
Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline?
Emma Louise Cunningham · Beaumont Hospital, Troy · funded by National Institutes of Health
2020–2027 · research · R33
Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline?
Emma Louise Cunningham · Beaumont Hospital, Troy · funded by National Institutes of Health
2019–2020 · contract · N02
BEAUMONT WILLIAM HOSPITAL:1107346 [19-029098] TISSUE SOURCE SITE (TSS)FOR NCI'S CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM CPTAC) CASES ELIGIBLE FOR PAYMENTS 1-4.
Jacque Li · Beaumont Hospital, Troy · funded by National Institutes of Health
2019–2020 · contract · N02
CLINICAL PROTEOMIC TUMOR ANALYSIS CONSORTIUM (CPTAC) IMAGING
Jaque Li · Beaumont Hospital, Troy · funded by National Institutes of Health
2019–2025 · research · R01
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2019–2024 · research · R01
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2019–2024 · research · R01
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2019–2024 · research · R01
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2019–2024 · research · R01
Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2018–2023 · career development · K01
Cancer Survivorship Research and Training in Radiation Cystitis
Bernadette Margaretha Maria Zwaans · Beaumont Hospital, Troy · funded by National Institutes of Health
2018–2023 · career development · K01
Cancer Survivorship Research and Training in Radiation Cystitis
Bernadette Margaretha Maria Zwaans · Beaumont Hospital, Troy · funded by National Institutes of Health
2018–2023 · career development · K01
Cancer Survivorship Research and Training in Radiation Cystitis
Bernadette Margaretha Maria Zwaans · Beaumont Hospital, Troy · funded by National Institutes of Health
2018–2021 · career development · K01
Cancer Survivorship Research and Training in Radiation Cystitis
Bernadette Margaretha Maria Zwaans · Beaumont Hospital, Troy · funded by National Institutes of Health
2017 · research · AARG
Salivary biomarkers of Alzheimer's disease
Stewart Graham · Beaumont Hospital, Troy · funded by Alzheimer's Association
2016–2021 · research · R01
Screening to Prophylax against C. difficile Infection (StoP CDI)
Matthew David Sims · Beaumont Hospital, Troy · funded by Agency for Healthcare Research and Quality
2016–2018 · research · R21
Biologic consequence and therapeuticimplications of cysteine catabolism in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health
2016–2021 · research · R01
Screening to Prophylax against C. difficile Infection (StoP CDI)
Matthew David Sims · Beaumont Hospital, Troy · funded by Agency for Healthcare Research and Quality
2016–2023 · research · R01
Screening to Prophylax against C. difficile Infection (StoP CDI)
Matthew David Sims · Beaumont Hospital, Troy · funded by Agency for Healthcare Research and Quality
2016–2021 · research · R01
Screening to Prophylax against C. difficile Infection (StoP CDI)
Matthew David Sims · Beaumont Hospital, Troy · funded by Agency for Healthcare Research and Quality
2016–2019 · research · R21
Biologic consequence and therapeuticimplications of cysteine catabolism in glioblastoma
Prakash Chinnaiyan · Beaumont Hospital, Troy · funded by National Institutes of Health